Sonoma Biotherapeutics Collaborated with Regeneron to Develop and Commercialize Treg Cell Therapies for Autoimmune Diseases
Shots: Sonoma to receive $75M up front incl. $45M in cash & $30M in equity inv...
Onconova Therapeutics Entered into a Research Collaboration with Pangea Biomed to Identify Biomarkers for Cancer Drug Rigosertib
Shots: The companies collaborated to identify biomarkers of response to Onconova&r...
Gilead Exercises its Option to License Nurix’s NX-0479 for Cancer
Shots: Nurix will receive $20M in option exercise fees and receive an additional ~...
Ono Entered into a Drug Discovery Collaboration Agreement with PeptiDream to Discover and Develop Macrocyclic Constrained Peptide...
Shots: PeptiDream to receive up-front, research funding & success-based milest...
Alnylam Expands its Collaboration with Medison Pharma to Commercialize RNAi Therapies
Shots: The companies have decided to expand their existing collaboration for RNA i...
ImmunoGen Signs a Multi-Target License and Option Agreement with Vertex to Develop Novel Targeted Conditioning Agents
Shots: ImmunoGen will receive $15M up front, ~$337M per target in option exercise...
